stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Revenue growth
Stevanato Group S.p.A.'s revenue growth over the twelve months to 30 September 2026 was 11.6%, down 0.7 percentage points from fiscal 2025 (12.3%). Over the past ten years it has ranged from −20.4% (fiscal 2019) to 32.0% (fiscal 2021); the current reading is higher than 57% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 12.3% | 10.64 |
| FY2024 | 1.70% | (11.64) |
| FY2023 | 13.3% | 9.54 |
| FY2022 | 3.80% | (28.23) |
| FY2021 | 32.0% | 6.20 |
| FY2020 | 25.8% | 46.26 |
| FY2019 | −20.4% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 5.91% | (4.55) |
| Jun 2026 | 10.5% | (7.99) |
| Mar 2026 | 18.5% | 5.38 |
| Dec 2025 | 13.1% | (2.91) |
| 21 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| TFX Teleflex Incorporated compare | 30.7% |
| ATRC AtriCure, Inc. compare | 13.8% |
| STVN Stevanato Group S.p.A. | 11.6% |
| WRBY Warby Parker Inc. compare | 9.89% |
| NVST Envista Holdings Corporation compare | 9.78% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| ICUI ICU Medical, Inc. compare | −5.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement